TXNIP and prostate carcinoma: We have previously reported that the basal expression of TXNIP was markedly reduced in metastatic prostate and breast cancer cell lines compared to their benign counterparts, and that the overexpression of TXNIP inhibited the migration of androgen-independent PC3 prostate cancer cells [48].